Skip to main content
OpenTrials
Completed

NCT Number: NCT01236742

Discontinuation of Orthokeratology on Eyeball Elongation in Myopic Children

The primary aim of this study is to compare eyeball elongation in existing ortho-k subjects who stop the treatment with subjects who continue ortho-k lens wear and control subjects wearing single-vision glasses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

School of Optometry, The Hong Kong Polytechnic University

Hong Kong, China

About this study

Children wearing ortho-k have been shown to have slower rate of myopic progression than those wearing single-vision spectacles (Cho et al. 2005) or soft lenses (Walline et al. 2009). Both studies showed that the effect of myopic control was most significant during the first six months of the treatment. It is unknown whether the myopic control effect would dissipate upon the discontinuation of the treatment or whether the myopic control effect only happened in the first six month of lens wear and was maintained thereafter. The current study aims at evaluating the effect of discontinuation of ortho-k treatment on myopic control in children who are currently on the treatment. This knowledge is necessary and important as patients/parents have concerns about the permanent dependency on ortho-k once they enrolled in the treatment.

Children who have been on the treatment for two years and have recently completed the myopic control studies at The Hong Kong Polytechnic University, i.e. the ROMIO, TO-SEE and HM-PRO studies, will be invited to participate in this 14-month study. Ortho-k subjects will be randomly assigned to study group or the ortho-k control group. The study group subjects will be required to stop lens wear for 7 months at the completion of the previous study (Phase I) and resume lens wear for next 7 months (Phase II). The ortho-k control group subjects will be required to continue the current treatment for another 14 months. Control subjects in the existing myopic control studies will be required to continue using the same treatment, i.e. single-vision glasses, for another 14 months. Rate of myopic progression among the 3 groups and at the two study phases will be determined and compared.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 8-14 years old (inclusive)
  • Subjects who have completed the ROMIO, TO-SEE or HM-PRO studies at The Hong Kong Polytechnic University
  • Willingness to be randomized into groups (for ortho-k subjects)
  • Availability for follow-up for at least 14 months

Exclusion criteria

  • Non-compliance to the follow up schedule
  • Non-compliance to the assigned optical correction (i.e. single-vision glasses or ortho-k lenses)
  • Contraindication for contact lens wear and ortho-k (e.g. limbus to limbus corneal cylinder and dislocated corneal apex)
  • Systemic or ocular) conditions which may affect contact lens wear (e.g. allergy and medication)
  • Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)

Treatment and study plan

ortho-k lenses

Device

nightly wear of orthokeratology lenses to correct vision

Other names: orthokeratology, corneal reshaping therapy, Menicon Z Night lenses, Menicon Z Night Toric lenses

single-vision glasses

Device

daily wear of spectacle glasses to correct vision

Other names: CR-39 lenses

Primary outcomes

  1. Change in Axial Length

    Time frame: Baseline, 7 months, and 14 months after baseline

    To determine the changes in axial length in the first 7 months and the last 7 months in the three groups of subjects

Secondary outcomes

  1. Incidence of Adverse Effects

    Time frame: 14 months

    The observation of serious and non-serious adverse events in the 14 months of study period

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Collaborators

  • Menicon Co., Ltd.

Registry information

Official study title

Discontinuation of Orthokeratology on Eyeball Elongation (DOEE) Study. (1) Discontinuation of Lens Wear in Existing Ortho-k Children

Acronym: DOEE1

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Nov 9, 2010
Registry last updated
Dec 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.